Khosrovi Behzad 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Feb 23, 2012
Insider Transaction Report
Form 4
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2012-02-17+52,083→ 486,283 totalExercise: $1.44From: 2012-03-30Exp: 2022-02-17→ Common Stock (52,083 underlying)
Footnotes (1)
- [F1]The options will vest and become exercisable in four equal installments: Twenty-five percent (25%) each on March 30, 2012, June 30, 2012, September 30, 2012 and December 30, 2012.